Fermion Oy Fermion Oy

X

90719-32-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
90719-32-7
Also known as: 90719-32-7, (s)-4-benzyloxazolidin-2-one, (4s)-4-benzyl-1,3-oxazolidin-2-one, (s)-(-)-4-benzyl-2-oxazolidinone, 2-oxazolidinone, 4-(phenylmethyl)-, (4s)-, Mfcd00064496
Molecular Formula
C10H11NO2
Molecular Weight
177.20  g/mol
InChI Key
OJOFMLDBXPDXLQ-VIFPVBQESA-N
FDA UNII
EC46HZ6ALH

1 2D Structure

90719-32-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S)-4-benzyl-1,3-oxazolidin-2-one
2.1.2 InChI
InChI=1S/C10H11NO2/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m0/s1
2.1.3 InChI Key
OJOFMLDBXPDXLQ-VIFPVBQESA-N
2.1.4 Canonical SMILES
C1C(NC(=O)O1)CC2=CC=CC=C2
2.1.5 Isomeric SMILES
C1[C@@H](NC(=O)O1)CC2=CC=CC=C2
2.2 Other Identifiers
2.2.1 UNII
EC46HZ6ALH
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 90719-32-7

2. (s)-4-benzyloxazolidin-2-one

3. (4s)-4-benzyl-1,3-oxazolidin-2-one

4. (s)-(-)-4-benzyl-2-oxazolidinone

5. 2-oxazolidinone, 4-(phenylmethyl)-, (4s)-

6. Mfcd00064496

7. (s)-4-(phenylmethyl)-2-oxazolidinone

8. (s)-4-benzyl-2-oxazolidone

9. (s)-(+)-4-benzyl-2-oxazolidinone

10. (-)-4-benzyl-2-oxazolidinone

11. (s)-4-benzyl-oxazolidin-2-one

12. 4-benzyl-1,3-oxazolidin-2-one #

13. (4s)-4-(phenylmethyl)-2-oxazolidinone

14. Ec46hz6alh

15. (s)-4-benzyloxazolidinone

16. Schembl4328

17. (4s)-4-(phenylmethyl)-1,3-oxazolidin-2-one

18. (s)-4-benzyl Oxazolidinone

19. 4(s)-benzyl-2-oxazolidinone

20. 4-(s)-benzyloxazolidin-2-one

21. (4s)-4-benzyl-2-oxazolidinone

22. (4s)-4-benzyloxazolidin-2-one

23. 4-(s)-benzyl-oxazolidin-2-one

24. Dtxsid00352970

25. (s)-4-benzyl-oxazolidine-2-one

26. Chebi:194622

27. (s)(-)4-benzyl-2-oxazolidinone

28. S-(+)-4-benzyl-2-oxazolidinone

29. (4s)-4-benzyl Oxazolidine-2-one

30. (s)-4-benzyl-oxazolidine-2- One

31. 4(s)-phenylmethyl-2-oxazolidinone

32. (4s)-4-benzyl 1,3-oxazolidinone

33. (s)(-)-4-benzyl-2-oxazolidinone

34. 4(s)-(-)-benzyl-2-oxazolidinone

35. Cs-d1593

36. (s)-4-phenylmethyl-2-oxazolidinone

37. (s)-(-)-4-benzyl-2-oxazolidineone

38. Akos015839020

39. (4s)-(-)-4-benzyl-2-oxazolidinone

40. (4s)4-benzyl-1,3-oxazolidin-2-one

41. (s)-4-benzyl-2-oxazolidinone, 99%

42. Ac-4357

43. Ps-6113

44. (s)-4-benzyl-1,3-oxazolidine-2-one

45. 4-benzyl-2-oxazolidinone, (s)-(-)-

46. Hy-41882

47. 4-(phenylmethyl)-2-oxazolidinone, (4s)-

48. 2-oxazolidinone, 4-(phenylmethyl)-, (s)-

49. Am20090806

50. B1754

51. En300-80370

52. Q-102352

53. Z1222283104

2.4 Create Date
2005-07-08
3 Chemical and Physical Properties
Molecular Weight 177.20 g/mol
Molecular Formula C10H11NO2
XLogP31.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area38.3
Heavy Atom Count13
Formal Charge0
Complexity187
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Brivaracetam
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY